DDrare: Database of Drug Development for Rare Diseases

Focetria (monovalent mf59-adjuvanted vaccine) (DrugBank: -)

3 diseases

ID	Disease name (Link within this page)	Number of trials
46	Malignant rheumatoid arthritis	1
49	Systemic lupus erythematosus	1
271	Ankylosing spondylitis	1

46. Malignant rheumatoid arthritis [ 4,183 clinical trials, 2,538 drugs, (DrugBank: 401 drugs), 183 drug target genes, 219 drug target pathways]

Searched query = "Malignant rheumatoid arthritis", "Rheumatoid arthritis", "Rheumatoid arthritis with vasculitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 4,183 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01006681 (ClinicalTrials.gov)	November 2009	31/10/2009	Vaccination Against Influenza H1N1 in Rheumatic Diseases	Efficacy and Safety of Vaccination Against Influenza H1N1 in Patients With Rheumatoid Arthritis, Systemic Lupus Erythematosus, Psoriatic Arthritis and Ankylosing Spondylitis Treated With Immunomodulatory Drugs	Influenza;Rheumatic Diseases	Biological: Focetria (Monovalent MF59-Adjuvanted vaccine)	Tel-Aviv Sourasky Medical Center	NULL	Not yet recruiting	18 Years	65 Years	Both	400	Phase 2	NULL

49. Systemic lupus erythematosus [ 827 clinical trials, 638 drugs, (DrugBank: 168 drugs), 108 drug target genes, 191 drug target pathways]

Searched query = "Systemic lupus erythematosus", "SLE"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 827 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01006681 (ClinicalTrials.gov)	November 2009	31/10/2009	Vaccination Against Influenza H1N1 in Rheumatic Diseases	Efficacy and Safety of Vaccination Against Influenza H1N1 in Patients With Rheumatoid Arthritis, Systemic Lupus Erythematosus, Psoriatic Arthritis and Ankylosing Spondylitis Treated With Immunomodulatory Drugs	Influenza;Rheumatic Diseases	Biological: Focetria (Monovalent MF59-Adjuvanted vaccine)	Tel-Aviv Sourasky Medical Center	NULL	Not yet recruiting	18 Years	65 Years	Both	400	Phase 2	NULL

271. Ankylosing spondylitis [ 531 clinical trials, 343 drugs, (DrugBank: 66 drugs), 41 drug target genes, 141 drug target pathways]

Searched query = "Ankylosing spondylitis", "Spondylarthritis ankylopoietica"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 531 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01006681 (ClinicalTrials.gov)	November 2009	31/10/2009	Vaccination Against Influenza H1N1 in Rheumatic Diseases	Efficacy and Safety of Vaccination Against Influenza H1N1 in Patients With Rheumatoid Arthritis, Systemic Lupus Erythematosus, Psoriatic Arthritis and Ankylosing Spondylitis Treated With Immunomodulatory Drugs	Influenza;Rheumatic Diseases	Biological: Focetria (Monovalent MF59-Adjuvanted vaccine)	Tel-Aviv Sourasky Medical Center	NULL	Not yet recruiting	18 Years	65 Years	Both	400	Phase 2	NULL